Status:
COMPLETED
Monocyte Distribution Width (MDW): An Early Marker of Sepsis in Patients With Comorbidities
Lead Sponsor:
Hôpital Universitaire Sahloul
Conditions:
Sepsis
Eligibility:
All Genders
18+ years
Brief Summary
In patients with the aforementioned comorbidities, septic conditions are common and associated with high mortality rates. Early diagnosis, along with prompt and appropriate management, has become a ma...
Detailed Description
We will test the effectiveness of MDW in the early diagnosis of sepsis as a factor of decompensation in patients with comorbidities: renal failure, heart failure, and COPD.
Eligibility Criteria
Inclusion
- Patients aged over 18 years admitted to the emergency department for decompensation of congestive heart failure or renal failure, or exacerbation of COPD.
Exclusion
- Patients who received antibiotic treatment in the past 7 days, pregnant women, children, non-consenting patients, patients with a history of malignant hematologic disease, polytransfused patients or those who recently received a transfusion, and patients whose MDW was not reported due to ineffective monocyte counting.
Key Trial Info
Start Date :
December 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 30 2025
Estimated Enrollment :
325 Patients enrolled
Trial Details
Trial ID
NCT06953154
Start Date
December 1 2023
End Date
June 30 2025
Last Update
August 21 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sahloul University Hospital
Sousse, Tunisia, 4021